The Recall Desk

Hazard

Mis Labeling recalls

9,611 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
9,611
Critical
161
Severe
589
Most recent
2026-09-24

Of the 9,611 mis labeling recalls we have scored against our rubric, 161 (2%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 589 (6%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all mis labeling recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

7776–7800 of 9611

  • ModerateFDA (Drugs)·D-994-2014·2014-01-29

    Sulfasalazine Tablets Recalled for Potential Labeling Mixup

    Aidapak Services is recalling 500 mg sulfasalazine tablets that may be mislabeled as fluconazole or phenytoin sodium.

    Product
    sulfaSALAzine, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603580121.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Devices)·Z-0814-2014·2014-01-29

    Bard Access Systems Recalls MRI Low Profile Ports with Undersized Catheters

    Bard Access Systems is recalling MRI Low Profile Single Lumen ports because some silicone catheters may be undersized to 5.3 Fr instead of the labeled 6.6 Fr.

    Product
    MRI Low Profile Single Lumen port with Open-Ended 6.6Fr Silicone Catheter. Product Code 0603880. Product Usage: The 6.6 Fr Open-Ended Single-Lumen venous catheters is packaged into various Bard Acess Systems finished goods as Attachable or Preconnected catheters in BardPort I
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-980-2014·2014-01-29

    Aidapak Recalls Aspirin/ER Dipyridamole Capsules Due to Labeling Error

    Aidapak Services, LLC is recalling Aspirin/ER Dipyridamole capsules because they may have been mislabeled as other medications.

    Product
    ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00597000160.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-908-2014·2014-01-29

    Aidapak Recalls Verapamil HCL ER Capsules Due to Labeling Error

    Aidapak Services, LLC is recalling Verapamil HCL ER capsules because they may have been mislabeled as Febuxostat tablets.

    Product
    VERAPAMIL HCL ER, Capsule, 240 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378644001.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-810-2014·2014-01-29

    Levothyroxine Sodium Tablets Recalled for Potential Labeling Error

    Aidapak Services, LLC is recalling Levothyroxine Sodium tablets due to a potential label mixup with Magnesium Chloride. The repacked drugs were distributed in four western states.

    Product
    LEVOTHYROXINE SODIUM, Tablet, 125 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074706890.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-772-2014·2014-01-29

    Aidapak Recalls Mycophenolate Mofetil Tablets Due to Labeling Error

    Aidapak Services, LLC is recalling 500 mg Mycophenolate Mofetil tablets because they may be mislabeled as 250 mg capsules.

    Product
    MYCOPHENOLATE MOFETIL, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00004026001.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-891-2014·2014-01-29

    Aidapak Recalls Atropine Sulfate/Diphenoxylate Tablets Due to Label Mixup

    Aidapak Services, LLC is recalling Atropine Sulfate/Diphenoxylate HCL tablets because they may have been mislabeled as Cyanocobalamin or Tri-Buffered Aspirin.

    Product
    ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378041501.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-996-2014·2014-01-29

    Aidapak Recalls Cholecalciferol Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling 5,000-unit Cholecalciferol tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.

    Product
    CHOLECALCIFEROL, Tablet, 5000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00761017840.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-836-2014·2014-01-29

    Aidapak Recalls Disopyramide Phosphate Capsules Due to Potential Labeling Error

    Aidapak Services, LLC is recalling Disopyramide Phosphate capsules because they may have been mislabeled as Thyroid tablets. The error could lead to patients receiving the wrong medication.

    Product
    DISOPYRAMIDE PHOSPHATE, Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093312901.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-997-2014·2014-01-29

    FDA Recalls Trifluoperazine Tablets Due to Potential Labeling Error

    Aidapak Services is recalling Trifluoperazine HCL tablets because they may have been mislabeled as Terbutaline Sulfate.

    Product
    TRIFLUOPERAZINE HCL, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781103001.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-871-2014·2014-01-29

    Fluconazole Tablets Recalled Due to Potential Labeling Errors

    Aidapak Services is recalling Fluconazole 200 mg tablets because they may have been mislabeled as Valsartan or Fluconazole 100 mg.

    Product
    FLUCONAZOLE, Tablet, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00172541360.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-869-2014·2014-01-29

    Repaglinide Tablets Recalled Due to Potential Labeling Mixup

    Aidapak Services is recalling Repaglinide 2 mg tablets because they may have been mislabeled as other prescription drugs.

    Product
    REPAGLINIDE, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00169008481.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-783-2014·2014-01-29

    Aidapak Recalls Pancrelipase DR Capsules Due to Potential Label Mixup

    Aidapak Services is recalling Pancrelipase DR capsules because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.

    Product
    PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, Rx only, Distributed by: AidaPak Service, LLC, NDC 00032121201.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Devices)·Z-0815-2014·2014-01-29

    Bard Access Systems Recalls Low Profile Ports with Undersized Catheters

    Bard Access Systems is recalling Low Profile Ports with 6.6 Fr catheters because some silicone catheters may be undersized to 5.3 Fr.

    Product
    Titanium Single Lumen Low-Profile port, with Pre-Attached open-Ended Silicone 6.6Fr Catheter. Product Code 0602180 Usage: The 6.6 Fr Open-Ended Single-Lumen venous catheters is packaged into various Bard Acess Systems finished goods as Attachable or Preconnected catheters in
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-882-2014·2014-01-29

    Aidapak Recalls Candesartan Cilexetil Tablets Due to Potential Labeling Error

    Aidapak Services, LLC is recalling Candesartan Cilexetil 16 mg tablets because they may have been mislabeled as Irbesartan 150 mg.

    Product
    CANDESARTAN CILEXETIL, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00186001631.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-1028-2014·2014-01-29

    Aidapak Recalls Niacin Tablets Due to Potential Labeling Mixup

    Aidapak Services, LLC is recalling Niacin 500 mg tablets because they may have been mislabeled as Naproxen or Docusate Sodium.

    Product
    NIACIN, Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904227260.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Devices)·Z-0792-2014·2014-01-29

    Remel Recalls Oxoid Cefpodoxime Antimicrobial Susceptibility Test Discs

    Remel Inc is recalling Oxoid Cefpodoxime 10 mcg. Antimicrobial Susceptibility Test Discs because some cartridges may contain discs not impregnated with antibiotic.

    Product
    Oxoid Antimicrobial Susceptibility Test Discs, Cefpodoxime 10 mcg., CT1612B, packaged in cartridges of 50 discs, 5 cartridges/pack. The firm name on the label is Oxoid Ltd., Basingstoke, Hampshire, England. Used in the semi-quantitative agar diffusion test method for in-vitro su
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-972-2014·2014-01-29

    Aidapak Recalls Cyclobenzaprine Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling 5 mg cyclobenzaprine tablets because they may have been mislabeled as ascorbic acid or atenolol.

    Product
    CYCLOBENZAPRINE HCL, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591325601.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-984-2014·2014-01-29

    Aidapak Recalls Hydrocortisone Tablets Due to Potential Labeling Errors

    Aidapak Services, LLC is recalling 5 mg hydrocortisone tablets because they may have been mislabeled as other prescription drugs.

    Product
    HYDROCORTISONE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603389919.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-917-2014·2014-01-29

    Aidapak Recalls Potassium Acid Phosphate Tablets Due to Labeling Error

    Aidapak Services, LLC is recalling Potassium Acid Phosphate 500 mg tablets because they may have been mislabeled as Prednisone 20 mg.

    Product
    POTASSIUM ACID PHOSPHATE, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00486111101.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-929-2014·2014-01-29

    Aidapak Recalls Calcium and Cholecalciferol Tablets Due to Labeling Errors

    Aidapak Services, LLC is recalling specific lots of calcium/cholecalciferol/sodium tablets because they may have been mislabeled as other medications.

    Product
    CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536342408.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-852-2014·2014-01-29

    FDA Recalls Doxazosin Mesylate Tablets Due to Potential Labeling Error

    Aidapak Services, LLC is recalling Doxazosin Mesylate 1 mg tablets that may be mislabeled as Pyridoxine HCl 100 mg.

    Product
    DOXAZOSIN MESYLATE, Tablet, 1 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00093812001.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-790-2014·2014-01-29

    Aidapak Recalls Lithium Carbonate ER Tablets Due to Labeling Errors

    Aidapak Services is recalling Lithium Carbonate ER tablets because they may be mislabeled as other medications. The repacked drugs were distributed in four western states.

    Product
    LITHIUM CARBONATE ER, Tablet, 450 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054002025.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-797-2014·2014-01-29

    Aidapak Recalls azaTHIOprine Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling azaTHIOprine 50 mg tablets because they may have been mislabeled as Selenium 50 mcg tablets.

    Product
    azaTHIOprine, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054408425.
    Category
    Drug
    Distribution
    4 states
  • ModerateFDA (Drugs)·D-912-2014·2014-01-29

    FDA Recalls Mislabeled Mesalamine DR Capsules Due to Label Mixup

    Aidapak Services, LLC is recalling Mesalamine DR capsules that may have been mislabeled as Chlorophyllin Copper Complex tablets.

    Product
    MESALAMINE DR, Capsule, 400 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00430075327.
    Category
    Drug
    Distribution
    4 states